UI study: Bone-loss drug shows promise against cancer
By Paul Wood
Thursday March 26, 2009
provided
From left, research scientists Yonghui Zhang and Rong Cao and chemistry Professor Eric Oldfield, all at the University of Illinois, are part of a team of 24 researchers around the world who have been conducting a cancer treatment study.
A drug used to treat bone loss has potential to be a cancer drug 200 times better at killing tumor cells than similar drugs, a University of Illinois professor said Wednesday.
The UI has been leading 24 researchers from the U.S., Europe, Taiwan and Japan for about four years in the study, which appears in this week's issue of the Journal of the American Chemical Society.
News-Gazette Archive
The full story is available in our paid story archive.
Find this article at:
http://www.news-gazette.com/news/2009/03/26/ui_study_bone-loss_drug_shows_promise_against_cancer
